Entering text into the input field will update the search result below

AbbVie Inc. (ABBV) Presents at 4th Annual Evercore ISI Virtual HealthCONx Conference (Transcript)

Dec. 02, 2021 2:07 PM ETAbbVie Inc. (ABBV) Stock
SA Transcripts profile picture
SA Transcripts

AbbVie Inc. (NYSE:ABBV) 4th Annual Evercore ISI Virtual HealthCONx Conference December 2, 2021 12:10 PM ET

Company Participants

Michael Severino - Vice Chairman and President

Robert Michael - Chief Financial Officer

Jeffrey Stewart - Executive Vice President of Commercial Operations

Carrie Strom - President of Global Allergan Aesthetics.

Conference Call Participants

Joshua Schimmer - Evercore ISI

Joshua Schimmer

All right. Welcome, everyone. It's Josh Schimmer from the Evercore ISI Biotech team. We're very pleased to introduce from AbbVie, we have Mike Severino, Vice Chairman and President; we have Rob Michael, Chief Financial Officer; Jeff Stewart, Executive Vice President of Commercial Operations; and also joined by Carrie Strom, President of Global Allergan Aesthetics. So got the whole team and a lot of ground to cover.

Question-and-Answer Session

Q - Joshua Schimmer

I'm going to start with a question really just to get it out of the way, why is everyone asking me about this AbbVie CF? Like it's the only topic that I get questions on. You may feel the same. Why is everyone still fixated on this? And what should we be looking for in the months or -- weeks or months ahead from the [transaction]?

Michael Severino

Well, there's obviously a lot of interest in that program. And quite frankly, I think much of it might come from the Vertex perspective rather than our perspective because if you think about this opportunity for us, it's a preclinical or rather a pre proof-of-concept clinical program. It's very heavily risk-adjusted. It's not anything that contributes meaningfully to our long-range plan at its current stage.

However, if we were to get positive proof-of-concept data, obviously, it does represent very nice upside because it's a very attractive market. And there are a lot of features of this market that play to our strengths. We're good at optimizing small

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About ABBV

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on ABBV

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.